KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

New York Times (NYT) Research & Development (2019 - 2025)

New York Times (NYT) has disclosed Research & Development for 7 consecutive years, with $66.9 million as the latest value for Q4 2025.

  • Quarterly Research & Development rose 8.28% to $66.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $264.3 million through Dec 2025, up 6.51% year-over-year, with the annual reading at $264.3 million for FY2025, 6.51% up from the prior year.
  • Research & Development hit $66.9 million in Q4 2025 for New York Times, roughly flat from $67.0 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $67.0 million in Q3 2025 to a low of $38.9 million in Q1 2021.
  • Historically, Research & Development has averaged $55.3 million across 5 years, with a median of $57.2 million in 2023.
  • Biggest five-year swings in Research & Development: skyrocketed 33.34% in 2022 and later grew 2.76% in 2025.
  • Year by year, Research & Development stood at $41.6 million in 2021, then soared by 33.34% to $55.5 million in 2022, then grew by 5.06% to $58.3 million in 2023, then increased by 6.01% to $61.8 million in 2024, then rose by 8.28% to $66.9 million in 2025.
  • Business Quant data shows Research & Development for NYT at $66.9 million in Q4 2025, $67.0 million in Q3 2025, and $63.9 million in Q2 2025.